Evasion of IFN-γ Signaling by Francisella novicida Is Dependent upon Francisella Outer Membrane Protein C by Nallaparaju, Kalyan C. et al.
Evasion of IFN-c Signaling by Francisella novicida Is
Dependent upon Francisella Outer Membrane Protein C
Kalyan C. Nallaparaju, Jieh-Juen Yu, Stephen A. Rodriguez, Xhavit Zogaj, Srikanth Manam, M. Neal
Guentzel, Janakiram Seshu, Ashlesh K. Murthy, James P. Chambers, Karl E. Klose, Bernard P.
Arulanandam*
South Texas Center for Emerging Infectious Diseases and Department of Biology, University of Texas at San Antonio, San Antonio, Texas, United States of America
Abstract
Background: Francisella tularensis is a Gram-negative facultative intracellular bacterium and the causative agent of the
lethal disease tularemia. An outer membrane protein (FTT0918) of F. tularensis subsp. tularensis has been identified as a
virulence factor. We generated a F. novicida (F. tularensis subsp. novicida) FTN_0444 (homolog of FTT0918) fopC mutant to
study the virulence-associated mechanism(s) of FTT0918.
Methods and Findings: The DfopC strain phenotype was characterized using immunological and biochemical assays.
Attenuated virulence via the pulmonary route in wildtype C57BL/6 and BALB/c mice, as well as in knockout (KO) mice,
including MHC I, MHC II, and mmT (B cell deficient), but not in IFN-c or IFN-cR KO mice was observed. Primary bone marrow
derived macrophages (BMDM) prepared from C57BL/6 mice treated with rIFN-c exhibited greater inhibition of intracellular
DfopC than wildtype U112 strain replication; whereas, IFN-cR KO macrophages showed no IFN-c-dependent inhibition of
DfopC replication. Moreover, phosphorylation of STAT1 was downregulated by the wildtype strain, but not the fopC mutant,
in rIFN-c treated macrophages. Addition of N
G-monomethyl-L-arginine, an NOS inhibitor, led to an increase of DfopC
replication to that seen in the BMDM unstimulated with rIFN-c. Enzymatic screening of DfopC revealed aberrant acid
phosphatase activity and localization. Furthermore, a greater abundance of different proteins in the culture supernatants of
DfopC than that in the wildtype U112 strain was observed.
Conclusions: F. novicida FopC protein facilitates evasion of IFN-c-mediated immune defense(s) by down-regulation of
STAT1 phosphorylation and nitric oxide production, thereby promoting virulence. Additionally, the FopC protein also may
play a role in maintaining outer membrane stability (integrity) facilitating the activity and localization of acid phosphatases
and other F. novicida cell components.
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Introduction
Francisella tularensis, a Gram-negative facultative intracellular
bacterium, causes the disease tularemia [1]. Of the F. tularensis
subspecies (subsp) described to date, those responsible for human
disease include the highly virulent subsp. tularensis (type A) and the
moderately virulent subsp. holarctica (type B) [2]. Although
Francisella novicida (also referred to F. tularensis subsp. novicida [3])
is avirulent in humans, it behaves similarly to F. tularensis in human
and mouse macrophages [4], shares biochemical features with F.
tularensis [3,5] and exhibits an LD50 in mice similar to F. tularensis
via the pulmonary route [2,6]. There also are notable differences
between F. novicida and F. tularensis, such as the LPS of F. novicida
being more stimulatory [7,8,9]. However, F. novicida has been an
attractive model for the study of the virulence mechanisms of F.
tularensis, given the genetic similarity (98.1% homology between
sequences common to U112 and SCHU S4) to F. tularensis [10],
and similar lifestyle within host cells.
Francisella can infect a variety of cell types including pulmonary
epithelial cells [11,12], dendritic cells [13], and hepatocytes [14],
but exhibits a strong tropism for replication within macrophages
[13]. The bacterial components responsible for the marked
virulence of Francisella are still largely unknown. Among the most
studied virulence factors are the Francisella pathogencity island
(FPI) genes, which encode a secretion system required for
phagosome escape and intramacrophage growth [15]. Additional
virulence factors have been identified, in particular a 58 kDa outer
membrane lipoprotein (FTT0918). This protein is truncated
(expressed as a fusion protein) in the live vaccine strain (LVS)
derived from F. tularensis subsp. holarctica [16], and reintroduction
of FTT0918 into LVS restored virulence to a level indistinguish-
able from a wildtype subsp. holarctica strain [17]. Moreover,
deletion of FTT0918 in F. tularensis subsp. tularensis also attenuates
virulence [16]. Given the importance of this outer membrane
lipoprotein (designated FopC) in F. tularensis virulence and
pathogenicity, we generated a defined F. novicida FTN_0444
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designated KKF332, and characterized the contribution of this
protein to the virulence of this microorganism. Our results
demonstrate that FopC plays a role in inhibition of IFN-c-
mediated host immune defense(s), thereby promoting virulence.
Results
Construction of the F. novicida fopC mutant, KKF332
In order to evaluate the role of FopC protein (FTN_0444) as a
virulence factor, we generated a fopC mutant of F. novicida using a
previously described Targetron insertion method [18]. Site-
specific insertion of a 0.9 kb-Ll.LtrB intron between nt. 444025
and 444026 of the F. novicida U112 genome resulted in a fopC
mutant, designated here as KKF332. Schematic representation of
the mutated fopC locus in KKF332 is shown in Fig. 1A. Disruption
and inactivation of the fopC gene in KKF332 was confirmed by
Southern and Western blot analyses, respectively. Southern blot
analysis (Fig. 1B) using an Ll.LtrB intron-specific probe [18]
detected a 5.2 Kb band which corresponded to the NdeI
restriction digestion product of the KKF332 fopC gene locus, but
not to the parental U112 strain. Western blot analysis (Fig. 1C)
using murine anti-FopC polyclonal antibodies demonstrated the
presence of a 58 kDa band in wildtype U112 cells, but not in fopC
mutant cells further confirming the lack of FopC protein
expression in KKF332.
Virulence of the fopC mutant is attenuated in a murine
pulmonary tularemia model
The fopC mutant was assessed for virulence in a murine
pneumonic tularemia model. To determine the LD50 of the fopC
mutant using this model, BALB/c mice (6/group) were inoculated
intranasally with an increasing dosage of strain KKF332. As
shown in Fig. 2A, the LD50 of the fopC mutant was between 10
4
and 10
5 CFU, which was approximately 1000 fold greater than
that of the wildtype U112 strain (,10 CFU or less; [19]). As
expected, all mice inoculated intranasally with 10
3 CFU of U112
(,100 LD50) succumbed to infection by day 5.
To further examine replication and dissemination of the fopC
mutant in comparison to the wildtype F. novicida strain, BALB/c
mice were challenged i.n. with 10
3 CFU of strains KKF332 or
U112, and bacterial burdens in the lungs, liver and spleen
determined. Both fopC mutant and wildtype strain recovery were
comparable in the lungs of infected mice at 1–2 days after
inoculation and both strains also could be recovered at similar
levels in the liver and spleen on the second day after challenge
(Fig. 2B). However, on day 3, bacterial burdens were significantly
(p,0.05) lower (1–2 logs) in all organs (lungs, liver and spleen) of
DfopC infected mice in contrast to mice infected with the wildtype
strain, which all succumbed to infection by day 5. In contrast, all
fopC mutant infected mice survived and the organism was
recovered at in increasing number in the lungs until day 7, with
the number of recovered bacteria decreasing at day 14.
Additionally, decreasing fopC mutant burdens were observed in
the liver and spleen between day 3 and day 14. Collectively,
reduced mortality and decreased bacterial burdens in the lungs,
liver, and spleen demonstrate that fopC mutant virulence is
attenuated, and that host immune responses could largely control
mutant strain replication.
IFN-c mediates fopC mutant attenuation in mice
Since IFN-c has been shown to be a predominant component of
the anti-Francisella protective immune response [20,21], we
compared survival of BALB/c IFN-c
+/+ and IFN-c
2/2 mice
following i.n. challenge with 10
3 CFU wildtype U112 or fopC
mutant. As shown in Fig. 2C, both IFN-c
+/+ and IFN-c
2/2 mice
challenged with U112 succumbed to infection within 6 days
following challenge. However, only IFN-c
2/2, not IFN-c
+/+, mice
succumbed within 7 days following DfopC challenge. BALB/c IFN-
c
+/+ mice challenged with DfopC survived for at least 30 days
following challenge. These results suggest that FopC may be
required to mediate resistance of F. novicida to elimination by
endogenous IFN-c. We also analyzed whether mice deficient in
endogenous IFN-c signaling (IFN-cR
2/2 mice) were susceptible
to KKF32 challenge similar to the IFN-c
2/2 mice. Moreover, we
used mice deficient in b2-microglobulin (MHC I
2/2 mice), MHC
II (MHC II
2/2 mice), or B cells (mmT mice), all lacking
components that have been shown to contribute to inducible
IFN-c production. We challenged C57BL/6 and different




2/2) intranasally with 10
3 CFU 112 (Fig. 3A) or fopC
mutant (Fig. 3B). All strains of mice succumbed to wildtype U112
infection by day 6. In contrast, the C57BL/6 mice and three of
four KO mouse strains (MHC-I
2/2, MHC-II
2/2, and mmT)
infected with the fopC mutant all survived for the entire period of
the experiment (30 days). The notable exception was IFN-cR
2/2
mice, which all succumbed to infection with the fopC mutant by 8
days.
Examination of replication and dissemination profiles indicated
wildtype U112 strain replication and kinetics of dissemination to
the liver and spleen were similar in C57BL/6 and IFN-cR
2/2
mice; although, higher (1–1.5 log10) numbers of bacteria were
recovered from the spleen and liver of IFN-cR
2/2 mice at days 2
and 3 (Fig. 4A). In comparison, the fopC mutant could be detected
in the liver of IFN-cR
2/2 mice one day earlier than in the liver of
C57BL/6 mice, and bacterial loads were significantly higher (1–
2.5 log10) in all tissues of IFN-cR
2/2 mice at day 3 post challenge.
Collectively, increased susceptibility of IFN-cR
2/2 mice to the
fopC mutant suggests that IFN-c was one of the host components
responsible for the attenuation of KKF332. These results
demonstrate that IFN-c signaling may play an important role in
controlling the clearance of the fopC mutant following bacterial
Figure 1. Generation of the fopC-null mutant (KKF332) of F.
novicida U112. (A) Schematic representation of Ll.LtrB intron insertion
in the fopC locus (FTN_0444) of KKF332. (B) Total genomic DNA, from
wildtype U112 and insertion fopC mutant strain (FTN_0444:: Ll.LtrB)
cells, was digested with NdeI and blots were probed using an intron-
specific probe. The number to the right of the panel indicates the
molecular mass in kilobases based on DNA standards. (C) U112 and fopC
strain cell lysates were separated by 10% SDS-PAGE, transferred onto a
PVDF membrane, and probed with polyclonal FopC antisera.
doi:10.1371/journal.pone.0018201.g001
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previous observations [22] showing that CD4
+ T cells are not
required in the effector phase of antibody-mediated IFN-c-
dependent anti-Francisella immunity. Thus, the primary source of
IFN-c to confer protective immunity against the fopC mutant may
come from innate immune cells such as macrophages and natural
killer cells.
IFN-c mediates inhibition of replication of the fopC
mutant within primary macrophages
Mononuclear phagocytes are an important component of innate
defenses against F. tularensis [1] and a primary site for intracellular
bacterial replication [23]. Thus, we compared replication of
wildtype U112 and fopC KKF332 strains in C57BL/6 and IFN-
cR
2/2 macrophages, previously stimulated with rIFN-c in order
to better understand how IFN-c signaling may control bacterial
replication. Bone marrow derived primary macrophages (BMDM,
2610
5/well) prepared from C57BL/6 and IFN-cR
2/2 mice were
infected (MOI 10 or 100) with either U112 or KKF332 in the
presence or absence of 1 ng/ml rIFN-c and viable bacteria within
the macrophages recovered at 3 and 24 h after inoculation. Since
initial (3 h) bacterial uptake/replication was comparable under all
conditions tested (data not shown), our studies were based on
comparisons carried out at 24 hours. Both wildtype and fopC
mutant bacteria replicated comparably in C57BL/6 and IFN-
cR
2/2 BMDM in the absence of rIFN-c (Fig. 5A, 10 MOI).
However, addition of rIFN-c to C57BL/6 BMDM resulted in
greater inhibition of intracellular fopC mutant replication (2.5–3.0
log10 reduction) than intracellular U112 replication (1.0–1.5 log10
reduction). Importantly, rIFN-c mediated inhibition in BMDM
was not observed in IFN-cR
2/2 macrophages, demonstrating that
Figure 3. Susceptibility of knockout mice to wildtype and fopC
mutant challenge. Different KO strains of mice (6/group) were
challenged i.n. with 10
3 CFU wildtype U112 (A) or fopC mutant (B).
Difference in survival between fopC mutant challenged C57BL/6 and
IFN-cR
2/2 mice was significant at a p,0.001. All animals were
monitored daily for survival over 30 days. (Representative of two
experiments.)
doi:10.1371/journal.pone.0018201.g003
Figure 2. Virulence of the fopC mutant. (A) BALB/c mice (6/group)
were challenged i.n. with 10
3 CFU U112 or increasing inocula (10
3–
10
6 CFU) of fopC mutant. All animals were monitored daily for survival
for 30 days. (B) BALB/C mice were challenged i.n. with 10
3 CFU wildtype
U112 or fopC mutant. Organs (lungs, liver and spleen) were collected on
days 1, 2, and 3 from mice (n=3 mice at each time point) infected with
U112 and on days 1, 2, 3, 7 and 14 postchallenge from mice infected
with the mutant, homogenized, and dilution plated for bacterial
enumeration. Results are presented as log10 CFU per organ (lower
detection limit was approximately 1000 CFU/organ). Differences
between replication of U112 and fopC strain on day 3 are significant
with P values ,0.05 represented by * in the figure. Death by day 7 of all
mice resulting from U112 challenge is represented by §. (C) BALB/c IFN-
c
+/+ and IFN-c
2/2 mice (8/group) were challenged i.n. with 10
3 CFU
wildtype U112 or fopC mutant. All animals were monitored daily for
survival over 30 days. Difference in survival between fopC mutant
challenged BALB/c and IFN-c
2/2 mice was significant at a p,0.001.
Difference in survival between fopC mutant and U112 wildtype
challenged BALB/c mice was significant at a p,0.001. (Representative
of two experiments.)
doi:10.1371/journal.pone.0018201.g002
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observed inhibition of bacterial replication. Moreover, these
results also indicate that the fopC mutant is more susceptible to
IFN-c-mediated killing within BMDM, when compared to the
U112 parental strain. Addition of rIFN-c to C57BL/6 BMDM
also resulted in increased inhibition of fopC mutant replication
compared to the wildtype U112 at 100 MOI (data not shown).
Recently, it has been reported that F. novicida downregulates the
IFN-c signaling pathway to evade host immunity [24]. Because we
observed greater inhibition of replication of the fopC mutant than of
the wildtype strain within rIFN-c treated macrophages, we sought
to determine the effect of the fopC mutant on the IFN-c signaling
pathway by examining phosphorylation of STAT1 (signal trans-
ducer and activator of transcription-1), a critical molecule in the
IFN-c pathway that binds and activates transcription of responding
genes (such as iNOS), as well as at the levels of nitric oxide (NO)
produced in BMDM infected with either the wildtype U112 or the
fopC mutant. Minimally phosphorylated STAT1 (p-STAT1) was
observed in mock infected BMDM or those infected with either
wildtype or fopC mutant strain in the absence of rIFN-c treatment
(Fig. 5B); whereas, addition of rIFN-c induced p-STAT1 in mock-
infected BMDM. However, despite addition of rIFN-c to BMDM
infected with the wildtype U112 strain, phosphorylation of STAT1
was greatly suppressed (Fig. 5B) in agreement with previous studies
from Roth and Parsa [24,25]. In contrast, rIFN-c treatment of
BMDM infected with the fopC mutant resulted in p-STAT1 levels
similar to that seen in rIFN-c treated mock infected cells.
Given that STAT1 activation can result in induction of NO, we
measured NO levels in culture supernatants of infected cells as
previously described. We observed significantly increased NO
production in rIFN-c-treated BMDM infected with the fopC
mutant compared to rIFN-c-treated cells infected with wildtype
U112 (Fig. 5C). Increased NO levels following rIFN-c treatment in
fopC mutant infected BMDM is all the more significant given that
the level of NO induced in the absence of IFN-c by fopC was
significantly lower than in BMDM infected with U112 (Fig. 5C).
These results suggest that the increased levels of NO production in
rIFN-c treated BMDM may contribute to the greater inhibition of
Figure 4. Dissemination of U112 and fopC mutant in C57BL/6
and IFN-cR
2/2 mice. Mice were challenged i.n. with 10
3 CFU wildtype
U112 (A) or fopC mutant (B). Organs (lungs, liver and spleen) were
collected on days 1, 2, and 3 postchallenge (n=3 at each time point),
homogenized, and dilution plated for bacterial enumeration. Results are
log10 CFU per organ (lower detection limit was approximately
1000 CFU/organ). Differences between replication of U112 and fopC
strains are significant with p values ,0.05 represented by * in the figure.
(Representative of two experiments.)
doi:10.1371/journal.pone.0018201.g004
Figure 5. IFN-c mediated inhibition of intramacrophage F.
novicida replication. (A) Bone marrow derived primary macrophages
(2610
5/well) from C57BL/6 or IFN-cR
2/2 mice were infected (10 MOI)
with wildtype U112 or fopC mutant in the presence or absence of 1 ng/
ml rIFN-c and numbers of viable bacteria at 24 h determined by lysing
the macrophages and dilution plating. Results are expressed as the
averages of values for three wells. (B) C57BL/6 macrophages (10
6/well)
were infected (10 MOI) with U112 or fopC strain in the presence or
absence of rIFN-c (1 ng/ml) for 3 h. Protein-matched lysates from 3 h
cultures with and without added rIFN-c were resolved by SDS PAGE and
analyzed by Western blotting with phosphotyrosine-STAT1 antibody or
actin antibody. (C) Nitric oxide concentration was determined in the
24 h supernatants using Griess reagent. Differences between NO levels
of U112 and fopC strains are significant with p values ,0.001 as
represented by * in the figure. (Representative of three experiments.)
doi:10.1371/journal.pone.0018201.g005
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wildtype strain. Collectively, these results suggest a role for FopC
in evading host IFN-c-mediated responses.
Characterization of the fopC mutant
Based upon predicted Signal Peptidase II cleavage site data,
FopC is considered to be a lipoprotein [26]. Membrane
lipoproteins can serve as structural proteins, enzymes, transporters,
or immune evasion molecules [27]. The fopC mutant, KKF332,
replicated similarly to U112 in both supplemented TSB and
Chamberlain’s medium within a 36 h growth period, and
exhibited similar sensitivity to several classes of antibiotics (Table
S1). However, biochemical characterization of KKF332 using
substrate embedded API-ZYM strips revealed aberrant localiza-
tion of acid phosphatase activity in the fopC mutant (Table S2).
Acid phosphatase activity was observed associated with the whole
cell fraction in the wildtype U112 strain; whereas, minimal acid
phosphatase activity was found in the culture supernatant. In
striking contrast, acid phosphatase activity of the fopC mutant was
observed predominantly in the culture supernatant, and less
associated with the whole cell fraction. This suggests that FopC
contributes to the normal localization of acid phosphatases.
Currently, five acid phosphatase genes have been identified
within the U112 genome and among these, AcpA is the major acid
phosphatase associated with the outer membrane [28]. In order to
determine if FopC is involved in proper localization of AcpA,
Western immunoblot analyses utilizing AcpA antisera were carried
out on U112 and KKF332 cell pellets and filtered culture
supernatants. These analyses revealed that AcpA was more
abundant in U112 pellets than in fopC mutant (Fig. 6A, WB). In
contrast, AcpA was only found in the supernatant of the fopC
mutant strain, but not in the supernatant of the wildtype U112
strain (Fig. 6B, WB). The presence of AcpA in the fopC mutant
culture filtrate was confirmed further by proteomic analysis of the
filtrate using Matrix Assisted Laser Desorption/Ionization-Time of
Flight mass spectrometry (Table S3). Moreover, there was a
greater abundance of different proteins in the supernatant of the
fopC mutant strain than in the supernatant of the wildtype U112
strain (Fig. 6B, Gel); although growth conditions and CFUs used to
generate the respective supernatants were similar. Some of the
proteins (Table S3) in the fopC culture supernatant were identified
by proteomic analysis with molecular weights ranging from 9 kDa
to 100 kDa. These proteins consist of putative cytoslic proteins
(e.g. DNA-binding protein HU-beta, isocitrate dehydrogenase),
periplasmic proteins (e.g. beta-lactamase class A), membrane
proteins (OmpA family protein, AcpA), and previously identified
secreted proteins (ChiA, ChiB, CpbA, PepO) [29] suggesting
proteins were released into culture through the ‘‘leaky’’ membrane
of the fopC mutant. Western blot analysis of another identified
protein, IglC, also revealed similar protein localization pattern to
AcpA (Fig. 6A and 6B). These results suggest that FopC protein
may play a role in maintaining outer membrane stability (integrity)
since in the absence of FopC, acid phosphatases (especially AcpA)
and a variety of other proteins normally cell associated could now
be found in the supernatant. To further confirm that the
membrane of the fopC mutant is less stable than the parental
U112 strain, we compared the susceptibility of both bacterial
strains to polymyxin B (PMB) treatment. Polymyxin B is a cationic
cyclic peptide with a fatty acid tail, which interacts with Gram-
negative bacterial membranes and affects membrane stability
[30,31,32]. As shown in Fig. 7C, the fopC mutant replicated in a
similar manner to U112 in the absence of PMB, but demonstrated
significantly (p,0.01) slower growth in the presence of 400 mg/ml
PMB at 24 and 48 h after bacterial inoculation. Moreover, the
sensitivity of F. novicida to PMB was dose-dependent, and the fopC
mutant exhibited greater sensitivity to PMB than U112 even at a
low concentration (25 mg/ml [p,0.01], Fig. 7D) suggesting
decreased F. novicida membrane stability in the absence of the
FopC protein.
Complementation of KKF332 with the fopC gene restores
virulence
In order to confirm that phenotypes associated with the
KKF332 strain are due only to the loss of FopC, we transformed
this strain with a plasmid (pfopC) that expresses fopC from its native
promoter. Expression of FopC in the complemented strain (fopC/
pfopC) was confirmed by Western blot analysis using anti-FopC
antibody (Fig. 7A). Given the marked difference in acid
phosphatase localization between the wildtype U112 and fopC
mutant strains, the cell pellet and culture supernatant material of
pfopC complemented strain was analyzed for localization of acid
phosphatase. As previously shown, wildtype U112 acid phospha-
tase activity is predominantly cell associated with little activity in
Figure 6. Biochemical characterization of fopC mutant pheno-
type. Total proteins from similarly prepared cell pellets (A) and
concentrated (60 fold) spent (36 h) culture supernatant (B) of U112 and
fopC mutant strain were separated by 10% SDS-PAGE and either stained
by silver reagents (Gel) or transferred onto a PVDF membrane and
probed with anti-AcpA antibody or anti-IglC antibody (WB).
doi:10.1371/journal.pone.0018201.g006
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fopC mutant strain is observed to be predominantly in the
supernatant, with little cell associated activity (Fig. 7B). When
fopC KKF332 was complemented with pfopC, localization of acid
phosphatase activity resembled that of the wildtype strain, i.e.,
high cell-associated levels of activity, in contrast to low activity
levels observed in the culture supernatant (Fig. 7B). Furthermore,
resistance to PMB damage was restored in the fopC complemented
(fopC/pfopC) strain similar to the level of wildtype U112 (Fig. 7C
and D). Complementation of fopC mutant with pfopC also restored
inhibition of p-STAT1 to a level similar to wildtype U112 in IFN-
c stimulated BMDM (Fig. 8A), and restored intramacrophage
replication in IFN-c treated BMDM to a level similar to that
observed for the wildtype strain (Fig. 8B). The inhibition of fopC
mutant replication in IFN-c treated BMDM might largely be due
to production of nitric oxide, an effector of IFN-c signaling since
addition of 0.25 mM N
G-monomethyl-L-arginine (L-NMMA), an
NOS inhibitor, led to an increase of fopC replication to a level
similar to that in the BMDM unstimulated with rIFN-c (Fig. 8B).
Finally, pfopC complementation restored virulence. C57BL/6 and
IFN-cR
2/2 mice (6/group) were challenged i.n. with 10
3 CFU
U112, the fopC mutant (KKF332) strain, or complemented
KKF332 carrying pfopC (fopC/pfopC); and monitored for 30 days.
As shown in Fig. 8C, all C57BL/6 mice succumbed to infection
with wildtype U112 within five days; whereas, all mice survived
infection with the fopC strain in agreement with the results
presented above. Importantly, complementation of the fopC
mutant with pfopC fully restored virulence (p,0.001 compared
to fopC mutant challenged mice), with all mice succumbing to
infection by day 6. Additionally, IFN-cR
2/2 mice infected with
U112, the fopC mutant (KKF332) strain, or KKF332 comple-
mented with pfopC succumbed to infection within eight days of
infection as expected and consistent with earlier results. These
results demonstrate that the attenuated virulence phenotype of
KKF332 is specifically dependent upon loss of FopC. Thus,
complementation of the KKF332 mutant with pfopC restored acid
phosphatase activity localization, inhibition of IFN-c-mediated
responses, as well as levels of virulence observed for the wildtype
organism in the murine pulmonary tularemia model.
Discussion
Francisella, as with other obligate intracellular and facultative
intracellular bacteria, has evolved various strategies to evade early
host immune defenses including inhibition of phagolysosomal
fusion [33,34] and early acidification [4,35,36]. Once the
organism escapes the phagosome, it replicates in the host cytosol
and induces apoptosis and lysis of infected cells. Additionally, the
infected host cells and extracellular bacteria lead to dissemination
of Francisella from the lung during pulmonary infection. In this
report, we describe the role of a F. novicida outer membrane
protein, FopC, in evasion of IFN-c signaling and virulence of this
organism in an experimental mouse model.
Evasion of IFN-c-mediated host immune defenses has been
characterized for a number of viruses [37,38] as well as for several
intracellular bacteria [39,40,41]. For example, Salmonella typhimur-
ium evades killing in activated macrophages by inhibition of IFN-c-
induced nitric oxide production. This evasion is dependent on the
Figure 7. Acid phosphatase activity and resistance to polymyxin B treatment are restored in a fopC-complemented strain. (A) U112,
fopC mutant and complemented fopC/pfopC cell lysates were separated by 10% SDS-PAGE and either stained with Coomassie blue (Gel) or
transferred onto a PVDF membrane and probed with polyclonal FopC antisera (WB). (B) U112, fopC and fopC/pfopC were grown for 36 h in
Chamberlain’s medium. Bacteria and respective concentrated (60 fold) culture filtrates were analyzed for acid phosphatase activity using p-
nitrophenylphosphate substrate. (C) Growth curves of U112, fopC mutant and complemented fopC/pfopC cells in Chamberlain’s medium 6
polymyxin B (400 mg/ml) over 48 h. *Difference in growth between fopC mutant and U112/complement strain was significant at a p,0.01 (D)
Inhibition of U112, fopC mutant and complemented fopC/pfopC cell growth in Chamberlain’s medium at 24 h by various concentration of polymyxin
B. Bacterial growth in the presence of polymyxin B is presented as % to corresponding bacterial strain grown in the absence of polymyxin B.
*Difference in growth between fopC mutant and U112/complement strain was significant at a p,0.01. (Representative of two experiments with
triplicates for B–D.)
doi:10.1371/journal.pone.0018201.g007
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employs a different mechanism to evade IFN-c-mediated host
defense to achieve persistent infection [42]. IFN-c-mediated
indoleamine 2,3-dioxygenase upregulation and tryptophan star-
vation affect the developmental cycle of Chlamydia trachomatis [42].
In the presence of exogenous indole, expression of functional
chlamydial tryptophan synthase has been shown to effectively
overcome IFN-c-mediated killing [43]. In contrast, F. tularensis
infections are more acute and rapidly fatal. Tridandapani and
colleagues [24] have shown that F. novicida infection of murine
macrophages results in suppression of IFN-c-induced STAT1
expression and phosphorylation. Our results now demonstrate a
plausible mechanism by which bacterial components are involved
in the F. novicida-mediated inhibition of IFN-c-mediated signaling.
IFN-c-treated primary macrophages exposed to the fopC mutant
exhibited greater levels of p-STAT1 as early as 3 h compared to
the wildtype strain. Moreover, fopC mutant-infected macrophages
also produced greater NO in the supernatant, and exhibited
greater inhibition of intracellular bacterial replication. This
inhibition of fopC replication was abrogated by the presence of a
NOS inhibitor suggesting that the IFN-c signaling effector, nitric
oxide, was important for control of fopC mutant infection.
During phenotypic characterization of the DfopC with API-
ZYM, we noticed that acid phosphatase activity, which is normally
cell-associated in the wildtype strain, was largely found in culture
supernatants of the fopC mutant. This raises the question whether
the aberrant acid phosphatase phenotype of the fopC mutant plays
a role in modulation of IFN-c signaling. It is quite plausible based
on (1) precedential evidence supporting the involvement of
phosphatase(s) in inhibition of IFN-c signaling; for example,
Vaccina virus inhibits IFN-c signaling via virus-associated
phosphatase activity (VH1) [37]; (2) a recent publication showing
F. novicida AcpA was capable of dephsophorylating other host
defense proteins [44]; and (3) our observation of macrophages
infected with a strain lacking four acid phosphatases (including
AcpA) showing no impairment of p-STAT1 formation, similar to
the fopC mutant (data not shown).
One interesting phenotype of the fopC mutant strain is that many
proteins are present in the culture supernatant of the DfopC strain
that are either absent or present at much lower levels in
supernatants from the wildtype strain. This suggests that FopC
functions to stabilize the outer membrane and that its absence leads
to outer membrane destabilization and release of multiple
membrane-associated proteins such as AcpA. Additional evidence
in the published literature appears to support membrane-stabiliza-
tion by FopC. Previous studies of Lindgren et al. [45] demonstrated
that a FTT0918 (fopC) mutant of F. tularensis subsp. tularensis exhibits
an inability to acquire iron bound to siderophores. We suggest that
destabilization of the outer membrane in the absence of FTT0918
(FopC) might lead to loss of the siderophore receptor, thus resulting
in the observed iron deficient phenotype. Experiments are currently
being carried out to test this hypothesis.
In summary, findings presented here indicate that the FopC
protein of F. novicida is a virulence determinant and functions to
Figure 8. Virulence is restored in a fopC-complemented strain. (A) C57BL/6 macrophages (10
6/well) were infected (10 MOI) with U112, fopC,
or complemented fopC/pfopC strain in the presence or absence of rIFN-c (1 ng/ml) for 3 h. Protein-matched lysates from 3 h cultures were resolved
by SDS PAGE and analyzed by Western blotting with phosphotyrosine-STAT1 and actin antibodies. The relative p-STAT1 levels of the three strains
were first normalized with respective b-actin level and compared to mock treated p-STAT1. (B) Bone marrow derived primary macrophages (2610
5/
well) from C57BL/6 or IFN-cR
2/2 mice were infected (10 MOI) with wildtype U112, fopC mutant or fopC/pfopC in the presence or absence of 1 ng/ml
rIFN-c and 0.25 mM NOS inhibitor L-NMMA, and numbers of viable bacteria at 24 h determined by macrophage lysing and dilution plating. Results
are expressed as the averages of values for three wells. Differences in bacterial replication within IFN-c activated macrophages between fopC mutant
and U112** or fopC/pfopC* were significant at a p,0.01** and p,0.05*, respectively. (C) C57BL/6 and IFN-cR
2/2 mice (n=6/group) were challenged
i.n. with 10
3 CFU U112, mutant fopC (KKF332) strain, or KKF332 strain complemented with pfopC (fopC/pfopC). Difference in survival in challenged
BALB/c mice between fopC mutant and complement strain was significant at a p,0.001. All animals were monitored daily for survival for 30 days.
(Representative of two-three experiments.)
doi:10.1371/journal.pone.0018201.g008
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factors such as AcpA which may be one of several F. novicida
bacterial components involved in the dephosphorylation of
STAT1 to inhibit IFN-c-mediated signaling. Together, our
findings support the importance of FopC in facilitating avoidance




Francisella novicida strain U112 was provided by Dr. Francis
Nano (University of Victoria, Canada). The F. novicida FTN_0444
(FopC) insertion mutant of U112 was generated using a Targetron
transformation system as described previously [18]. Briefly, U112
was transformed using plasmid pKEK1220 (372|373s) via
electroporation (600V,2 5 mF, 2.5 kV; BIO-RAD Gene Pulser
II). The pKEK1220 plasmid was constructed by retargeting the
Ll.LtrB intron in pKEK1140 using intron binding site primer IBS
(59-AAAACTCGAGATAATTATCCTTAAAAAACCCTCGT-
GTGCGCCCAGATAGGGT G), and two exon binding site
primers EBS1 (59-CAGATTGTACAAATGTGGTGATA ACA-
GATAAGTCCCTCGTACTAACTTACCTTTCTTTGT) and
EBS2 (59-TGAACGCAAGTTTCTAATTTCGGTTTTTTTC-
CGATAGAGGAAAGTGTCT) as described previously [18].
The fopC mutant, KKF332 (FTN_0444:: Ll.LtrB), was obtained
by PCR screening using gene-specific and intron-specific primers
and further verified by DNA sequencing and Southern analysis.
Complemented strain DfopC/pfopC was generated via electropora-
tion(as described above) using the complementationplasmid (pfopC)
containing fopC coding sequences plus its putative promoter
(,200 bp upstream) PCR amplified from U112 DNA using gene
specific primers (59-CGGAATTCCATGGACACCGACGTAT-
GCAC and 59-AAGAAAAAAGCGGCCGC TTATACGTA-
TACCGACATATCCAG).
Mice
Female mice were used in all experiments. Four to six week old
BALB/c and C57BL/6 mice were purchased from the National
Cancer Institute (Bethesda, MD). BALB/c IFN-c
2/2 [46] and
C57BL/6 MHC I (b2m)
2/2 mice [47], MHC II (H2)
2/2 mice
[48], mMT (B-cell deficient) mice [49] and IFN-cR
2/2 [50] mice
were purchased from the Jackson Laboratory (Bar Harbor, ME,
USA). Mice were housed at the University of Texas at San
Antonio animal facility and all experimental procedures were
approved by the UTSA Institutional Animal Care and Use
Committee (IACUC: MU031-11/11A7).
Intranasal challenge and bacterial dissemination
Mice were first anesthetized with 3% isoflurane, using a rodent
anesthesia system (Harvard Apparatus, Holliston, MA), and then
inoculated intranasally (i.n.) with respective doses of F. novicida
strains in 25 ml of phosphate-buffered saline (PBS). The actual
CFU administered in each experiment was determined by dilution
plating of inocula on supplemented TSA. For survival experi-
ments, animals were monitored daily for morbidity and mortality.
For bacterial dissemination assays, mice were challenged i.n. with
10
3 CFU of U112 (lethal dose) or KKF332 (sublethal dose). At 1,
2, and 3 days postchallenge with U112 infected mice and at 1, 2, 3,
7, and 14 days with KKF332 infected mice (3 mice at each time
point), lungs, livers, and spleens were collected into 3 ml of
Dulbecco’s modified Eagle’s medium containing 4.5 g/L glucose,
L-glutamine, sodium pyruvate (DMEM; Mediatech, Fairfax, VA)
and supplemented with 10% (v/v) fetal bovine serum (D10;
HyClone, Logan, UT), homogenized, adjusted to a final volume of
5 ml and dilution plated on supplemented TSA for bacterial
enumeration. Survival data indicate no significant differences
between the two strains (BALB/c and C57BL/6) of mice used in
this study with regard to U112 or fopC mutant susceptibility. None
of the U112-infected mice survived past day 7.
Antibodies
For generation of polyclonal antisera against FopC, 10 mg
recombinant FopC protein was emulsified in an equal volume of
complete Freund’s adjuvant and injected intraperitoneally into 4
to 6-week-old, female BALB/c mice. After 2 weeks, mice were
boosted with the same amount of protein with incomplete
Freund’s adjuvant. Anti-FopC sera were prepared 2 weeks post
boost. Antibodies specific for phosphotyrosine-STAT1 were
purchased from Cell Signaling Technology (Beverly, MA). b-actin
antibody was purchased from Sigma-Aldrich (St. Louis, MO).
AcpA antiserum was a gift from Dr. Thomas Reilly (University of
Missouri).
Infection of macrophages
Primary macrophages were prepared from murine bone
marrow cells as previously described [51]. These bone marrow
derived macrophages (BMDM) were washed with DMEM and
resuspended to a density of 10
6 cells/ml in D10. For intrama-
crophage growth assays, the suspension was aliquoted in 200 ml
volumes per well in 96-well tissue culture plates and incubated for
2 h with U112 or KKF332 bacteria at a multiplicity of infection
(MOI) of 10 or 100 bacteria/macrophage followed by 1 h
gentamicin (GIBCO BRL, Grand Islands, N.Y.) treatment
(20 mg/ml) to kill extracellular organisms. Wells were replenished
with D10 and cells were grown at 37uC in a 5% CO2 incubator for
an additional 21 h. Measurements of intramacrophage bacteria at
24 h post inoculation were performed as previously described [52].
In IFN-c signaling assay experiments, BMDM were seeded into 6-
well plates at a concentration of 10
6 cells/well in 1 ml D10
overnight, and treated with 1 ng/ml rIFN-c (eBioscience) for 2 h
followed by inoculation with 10 MOI wildtype or mutant bacteria.
A dose titration experiment was initially carried out to determine
the optimal IFN-c concentration for intramacrophage replication
and 1 ng/ml concentration was used in subsequent IFN-c
signaling studies because of the maximal (but not saturated) effect
on control of DfopC replication. BMDM were lysed after 3 h
incubation by adding 100 ml SDS sample buffer (62.5 mM Tris-
HCl, pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM DTT, 0.01%
w/v bromophenol blue) per well, sonicated for 15–20 sec, and
centrifuged (12,0006g, 10 min). Culture filtrates (30 ml) of these
cells were analyzed for p-STAT1 by Western blotting using
monoclonal antibody per manufacturer’s recommendations (Cell
Signaling Technology).
API-ZYM and acid phosphatase assays
U112 or mutant strains were grown with an inoculum of 100 ml
(OD600=0.5) in 30 ml Chamberlain’s medium [53] for 36 hrs.
Bacteria were collected by centrifugation and adjusted to an
OD600 of 0.3. The culture supernatants (following centrifugation)
were filtered through 0.22 mm filters, and concentrated to 0.5 ml
using a 10,000 MW cut-off Centripreps (Millipore, Billerica, MA).
Bacteria (65 ml) or the concentrated culture filtrates were added to
API-ZYM strips (bioMeriux, Inc, Durham, NC), incubated for 4 h
at 37uC and analyzed for enzymatic profiles according to
manufacturer’s instructions. Quantitative acid phosphatase activ-
ity was determined by release of p-nitrophenol (pNP) from p-
nitrophenylphosphate substrate (pNPP; Sigma Chemical, St.
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OD600=1 of bacteria were added to 100 ml 50 mM citric acid
buffer (pH 5) containing 7.6 mM pNPP in a 96-well plate,
incubated at 37uC for 5 h, and the production of pNP measured at
410 nm using a microplate reader (mQuant; Biotek Instruments,
Winooski, VT).
Determination of nitrite concentration
The concentration of nitrite in cell supernatants was estimated
using the Griess reagent [55]. Briefly, 100 ml supernatant was
mixed with 50 ml Griess reagent and incubated at room
temperature in the dark for 30 min. Absorbance was measured
at 520 nm and nitrite concentrations determined by extrapolation
using a NaNO2 standard curve (1–100 mM).
Inhibition of bacterial growth by polymyxin B
Log phase F. novicida bacterial strains were used to inoculate
200 ml Chamberlain’s medium (to an OD600=0.05) per well
containing various concentration of polymyxin B sulfate salt (0–
1.6 mg/ml, Sigma) in 96 well polystyrene microplates. Bacteria
were allowed to growth for up to 48 h in a 37uC incubator and the
turbidity of bacterial cultures was measured at 600 nm at 4, 8, 24
and 48 h after inoculation using a microplate reader.
Statistical analysis
SigmaStat (Systat Software Inc., San Jose, CA) was used to
perform all tests of significance. Statistical analyses for survival
experiments were performed using the Kaplan-Meier test. The
Student’s t test was used to determine differences in in vitro and in
vivo bacterial replication. Data are all presented as mean values 6
the respective standard deviation.
Supporting Information
Table S1 Inhibition of F. novicida growth by various classes of
antibiotics. F. novicida wildtype U112 and fopC mutant strain were
grown to 0.6 OD600, diluted to a Mcfarland 1 standard and 100 ml
of each culture was confluently spread onto Mueller-Hinton agar
plates, and the antibiotic discs placed on the plates. The plates
were incubated at 37uC overnight and the zones of inhibition in
mm measured around each disc. Data presented above is the
average of readings from three discs of each antimicrobial.
(DOCX)
Table S2 Enzymatic characterization of wildtype U112 and fopC
mutant using the API-ZYM kit. * Intensity of the color reactions
was graded from 0 to 5 according to an API-ZYM color reaction
chart.
(DOCX)
Table S3 Proteins identified in the culture supernatant of the
fopC mutant. The fopC mutant was grown in Chamberlain’s
medium for 36 h. Culture filtrate was concentrated using 10,000
MW cut-off Centripreps, digested with trypsin, and subjected to
proteomic analysis using Matrix Assisted Laser Desorption/
Ionization-Time of Flight mass spectrometry. Each of the
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